- Home
- RVPH vs PYN Comparison
RVPH vs PYN Comparison
Compare RVPH & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- PYN
- Stock Information
- Founded
- RVPH 2006
- PYN 2002
- Country
- RVPH United States
- PYN United States
- Employees
- RVPH N/A
- PYN N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- PYN Investment Managers
- Sector
- RVPH Health Care
- PYN Finance
- Exchange
- RVPH Nasdaq
- PYN Nasdaq
- Market Cap
- RVPH 32.8M
- PYN 30.1M
- IPO Year
- RVPH N/A
- PYN N/A
- Fundamental
- Price
- RVPH $0.40
- PYN $5.22
- Analyst Decision
- RVPH Strong Buy
- PYN
- Analyst Count
- RVPH 5
- PYN 0
- Target Price
- RVPH $9.00
- PYN N/A
- AVG Volume (30 Days)
- RVPH 3.8M
- PYN 19.9K
- Earning Date
- RVPH 08-13-2025
- PYN 01-01-0001
- Dividend Yield
- RVPH N/A
- PYN 5.07%
- EPS Growth
- RVPH N/A
- PYN N/A
- EPS
- RVPH N/A
- PYN N/A
- Revenue
- RVPH N/A
- PYN N/A
- Revenue This Year
- RVPH N/A
- PYN N/A
- Revenue Next Year
- RVPH N/A
- PYN N/A
- P/E Ratio
- RVPH N/A
- PYN N/A
- Revenue Growth
- RVPH N/A
- PYN N/A
- 52 Week Low
- RVPH $0.30
- PYN $4.84
- 52 Week High
- RVPH $4.28
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- RVPH 36.63
- PYN 44.30
- Support Level
- RVPH $0.38
- PYN $5.21
- Resistance Level
- RVPH $0.45
- PYN $5.37
- Average True Range (ATR)
- RVPH 0.04
- PYN 0.11
- MACD
- RVPH 0.01
- PYN -0.00
- Stochastic Oscillator
- RVPH 58.54
- PYN 3.26
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.